Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

801
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
801
Glaucoma: Overview01:25

Glaucoma: Overview

1.0K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

926
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
926
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

7.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boats on the rocks: Late prehistoric nautical iconography and landscape, from Northwest Iberia to Scandinavia.

PloS one·2026
Same author

Impact of mono- or multitherapy on ocular surface health and quality of life after 5 years of follow-up in the Glaucoma Intensive Treatment Study (GITS).

Acta ophthalmologica·2026
Same author

New investigations of the Hjortspring boat: Dating and analysis of the cordage and caulking materials used in a pre-Roman iron age plank boat.

PloS one·2025
Same author

Seafaring and navigation in the Nordic Bronze Age: The application of an ocean voyage tool and boat performance data for comparing direct open water crossings with sheltered coastal routes.

PloS one·2025
Same author

Ten years of visual field change in people living with diabetes: A prospective longitudinal study.

PloS one·2025
Same author

Corrigendum to "The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development" [Am J Ophthalmol 2024;266:274-288].

American journal of ophthalmology·2025

Related Experiment Video

Updated: Nov 10, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.6K

Screening for Open-Angle Glaucoma and Its Effect on Blindness.

Johan Aspberg1, Anders Heijl1, Boel Bengtsson1

  • 1Department of Clinical Sciences in Malmö, Ophthalmology, Lund University, Malmö, Sweden.

American Journal of Ophthalmology
|April 6, 2021
PubMed
Summary
This summary is machine-generated.

Population screening for open-angle glaucoma significantly reduced blindness and low vision by approximately 50%. This study highlights the effectiveness of early detection through screening in preventing severe vision loss from glaucoma.

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.6K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K

Related Experiment Videos

Last Updated: Nov 10, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.6K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.6K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K

Area of Science:

  • Ophthalmology
  • Public Health
  • Epidemiology

Background:

  • Open-angle glaucoma is a leading cause of irreversible blindness worldwide.
  • Early detection and intervention are crucial for managing glaucoma and preventing vision loss.
  • Population-based screening programs aim to identify individuals with glaucoma or at high risk before significant vision impairment occurs.

Purpose of the Study:

  • To evaluate the impact of a population-based screening program on the incidence of low vision and blindness caused by open-angle glaucoma.
  • To compare the rates of vision impairment in a screened population versus a comparable non-screened group.

Main Methods:

  • A retrospective cohort study analyzed data from a large population-based glaucoma screening conducted in Malmö, Sweden (1992-1997).
  • Records of 32,918 screened individuals and a comparison group of potential participants were reviewed up to December 31, 2017.
  • Selection bias was addressed by constructing a comparison group from clinical patients, and outcomes (low vision/blindness) were assessed using WHO definitions.

Main Results:

  • The cumulative incidence of blindness was 0.17% in the screened population versus 0.32% in the potential participants.
  • The cumulative incidence of low vision was 0.25% in the screened group compared to 0.53% in the potential participants.
  • The risk ratio for blindness was 0.52 (95% CI, 0.32-0.84) and for low vision was 0.46 (95% CI, 0.31-0.68), indicating a significant reduction in both outcomes.

Conclusions:

  • Population screening for open-angle glaucoma appears to be effective in reducing the incidence of bilateral low vision and blindness.
  • The study suggests that screening can decrease the risk of severe vision impairment from glaucoma by approximately 50%.
  • These findings support the implementation and continuation of public health initiatives for glaucoma screening.